Latent tuberculosis infection screening for laboratory personnel using interferon-γ release assay and tuberculin skin test in Korea: An intermediate incidence setting

Journal of Clinical Laboratory Analysis

Volumn 25, Issue 6, 2011, Pages 382-388

  Moon, Hee Won ^a   Kim, Hanah ^a   Hur, Mina ^a   Yun, Yeo Min ^a   Lee, Anna ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Seoul Medical Science Institute   (South Korea)

Author keywords

Laboratory personnel; QuantiFERON TB Gold In Tube test; Tuberculin skin testx; Tuberculosis

Indexed keywords

GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CHEMISTRY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOLOGY; INTERMETHOD COMPARISON; KOREA; LABORATORY PERSONNEL; LABORATORY TEST; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; QUANTIFERON TB GOLD IN TUBE TEST; TUBERCULIN TEST;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MEDICAL LABORATORY PERSONNEL; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REPUBLIC OF KOREA; TUBERCULIN TEST;

EID: 81255178588     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20479     Document Type: Article

References (30)

1. Lee K, Han MK, Choi HR, et al. Annual incidence of latent tuberculosis infection among newly employed nurses at a tertiary care university hospital. Infect Control Hosp Epidemiol 2009;30:1218-1222.
2. Lew WJ, Lee EG, Bai JY, et al. An Internet-based surveillance system for tuberculosis in Korea. Int J Tuberc Lung Dis 2006;10:1241-1247.
3. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54:1-141.
4. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006;27:442-448.
5. Mazurek M, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010;59:1-25.
6. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med 2008;149:177-184.
7. Lee SS, Liu YC, Huang TS, et al. Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers. Scand J Infect Dis 2008;40:373-380.
8. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: Comparison of a whole-blood interferon gamma assay with tuberculin skin testing. J Am Med Assoc 2005;293:2746-2755.
9. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: What is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192-1204.
10. Liebeschuetz S, Bamber S, Ewer K, et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: A prospective cohort study. Lancet 2004;364:2196-2203.
11. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000;161:S221-S247.
12. Huebner RE, Schein MF, Bass Jr JB. The tuberculin skin test. Clin Infect Dis 1993;17:968-975.
13. Kang YA, Lee HW, Hwang SS, et al. Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007;132:959-965.
14. Lee JY, Choi HJ, Park IN, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006;28:24-30.
15. Harada N, Higuchi K, Mori T. Assessment of nosocomial transmission of tuberculosis in a psychiatric hospital using a whole blood interferon-gamma assay. Jpn J Infect Dis 2008;61:415-418.
16. Schablon A, Harling M, Diel R, Nienhaus A. Risk of latent TB infection in individuals employed in the healthcare sector in Germany: A multicentre prevalence study. BMC Infect Dis 2010;10:107.
17. Torres Costa J, Silva R, Sa R, Cardoso MJ, Nienhaus A. Results of five-year systematic screening for latent tuberculosis infection in healthcare workers in Portugal. J Occup Med Toxicol 2010;5:22.
18. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361:1168-1173.
19. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. J Am Med Assoc 2001;286:1740-1747.
20. Hill PC, Brookes RH, Fox A, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 2004;38:966-973.
21. Karalliedde S, Katugaha LP, Uragoda CG. Tuberculin response of Sri Lankan children after BCG vaccination at birth. Tubercle 1987;68:33-38.
22. Schablon A, Beckmann G, Harling M, Diel R, Nienhaus A. Prevalence of latent tuberculosis infection among health care workers in a hospital for pulmonary diseases. J Occup Med Toxicol 2009;4:1.
23. Alonso-Echanove J, Granich RM, Laszlo A, et al. Occupational transmission of Mycobacterium tuberculosis to health care workers in a university hospital in Lima, Peru. Clin Infect Dis 2001;33:589-596.
24. Kassim S, Zuber P, Wiktor SZ, et al. Tuberculin skin testing to assess the occupational risk of Mycobacterium tuberculosis infection among health care workers in Abidjan, Cote d'Ivoire. Int J Tuberc Lung Dis 2000;4:321-326.
25. The Global Plan to Stop TB, 2006-2015. actions for life: Towards a world free of tuberculosis. Int J Tuberc Lung Dis 2006;10:240-241.
26. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008;177:1164-1170.
27. Fox BD, Kramer MR, Mor Z, et al. The QuantiFERON-TB-GOLD assay for tuberculosis screening in healthcare workers: A cost-comparison analysis. Lung 2009;187:413-419.
28. Deuffic-Burban S, Atsou K, Viget N, Melliez H, Bouvet E, Yazdanpanah Y. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection. Int J Tuberc Lung Dis 2010;14:471-481.
29. Hardy AB, Varma R, Collyns T, Moffitt SJ, Mullarkey C, Watson JP. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: The QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries. Thorax 2010;65:178-180.
30. Linertova R, Alvarez-Leon EE, Garcia-Perez L, Serrano-Aguilar P. Costs of QuantiFERON-TB Gold versus tuberculin skin test in Spanish healthcare workers. J Hosp Infect 2010;75:52-55.